scispace - formally typeset
J

Jaume Reventós

Researcher at International University Of Catalonia

Publications -  114
Citations -  7992

Jaume Reventós is an academic researcher from International University Of Catalonia. The author has contributed to research in topics: Endometrial cancer & Cancer. The author has an hindex of 39, co-authored 111 publications receiving 6408 citations. Previous affiliations of Jaume Reventós include Autonomous University of Barcelona & University of Lleida.

Papers
More filters
Journal ArticleDOI

Biological properties of extracellular vesicles and their physiological functions

María Yáñez-Mó, +72 more
TL;DR: A comprehensive overview of the current understanding of the physiological roles of EVs is provided, drawing on the unique EV expertise of academia-based scientists, clinicians and industry based in 27 European countries, the United States and Australia.
Journal Article

Frameshift mutations at mononucleotide repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype.

TL;DR: Endometrial carcinoma of the MMP also accumulates mutations in genes that are typically mutated in gastrointestinal cancer of the mutator pathway, including BAX, hMSH3, and h MSH6, and caspase-5 is suggested as a new target gene in the microsatellite mutator pathways for cancer.
Journal ArticleDOI

Identification of necrotic cell death by the TUNEL assay in the hypoxic-ischemic neonatal rat brain.

TL;DR: Results, obtained in a paradigm of necrosis in the immature brain, add to previous evidence suggesting that some forms of non-apoptotic DNA fragmentation are labeled by the TUNEL assay.
Journal ArticleDOI

Prevalence of osteoporosis during long-term androgen deprivation therapy in patients with prostate cancer.

TL;DR: The prevalence of osteoporosis seemed high in hormone-naive patients with prostate cancer, and it increased to more than 80% after 10 years ofADT, and clinicians should be aware of the impact of ADT on BMD to prevent bone mass loss.
Journal ArticleDOI

Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro

TL;DR: T-PA specifically binds to annexin II on the extracellular membrane of pancreatic cancer cells where it activates local plasmin production and tumour cell invasion.